logo
Biologics for Crohn's Disease: 6 Ways They May Benefit You

Biologics for Crohn's Disease: 6 Ways They May Benefit You

Health Line7 hours ago
If other treatments haven't worked for you, biologics may be worth considering for managing Crohn's disease. In certain instances, they can be an excellent treatment option.
As someone living with Crohn's disease, you've likely heard about biologics. These are a type of prescription drug administered via an injection or intravenous (IV) drip. They manage inflammation by blocking certain proteins or chemical pathways.
You may have thought about trying them yourself. Here are six reasons this advanced type of treatment may be helpful for you and what you may want to consider.
Your Crohn's isn't responding to traditional treatments
Perhaps you've been taking different Crohn's disease medications, such as steroids and immunomodulators, for a while now. However, you're still having flare-ups several times a year.
American College of Gastroenterology guidelines strongly recommend taking a biologic agent if you have moderate to severe Crohn's disease that's resistant to steroids or immunomodulatory therapy.
Your doctor may also consider combining a biologic with an immunomodulator, even if you haven't tried those drugs separately yet.
You have a new diagnosis
Traditionally, treatment plans for Crohn's disease involved a step-up approach. Less expensive drugs, like steroids, were tried first, while more expensive biologics were a last resort.
More recently, guidelines have suggested a top-down approach with a new diagnosis. This is when stronger drugs are tried first, as evidence has pointed to better results when biologic treatments are started right after diagnosis.
A 2021 review of 31 trials found that for people with moderate to severe Crohn's disease, the combination of a biologic drug (infliximab) with a non-biologic drug (azathioprine) had the most promising results for managing symptoms.
The 2025 ACG guidelines also recommend the combination of both drugs over either individually.
You experience a complication known as fistulas
Fistulas are abnormal connections between body parts. In Crohn's disease, a fistula can occur when an ulcer extends through your intestinal wall, which connects your intestine and skin, or your intestine and another organ.
If a fistula becomes infected, it can be life threatening. If you have a fistula, your doctor may prescribe biologics known as TNF inhibitors because they're so effective.
The Food and Drug Administration (FDA) has approved biologics specifically to treat Crohn's disease with fistulas and to maintain fistula closure.
You want to maintain remission
Corticosteroids are known to bring about remission but aren't able to maintain that remission. If you've been taking steroids for 3 months or longer, your doctor may suggest you try a biologic instead.
Clinical studies show that anti-TNF biologics are able to maintain remission in people with moderately severe Crohn's disease.
Researchers note that the benefits of these drugs in maintaining remission generally outweigh the risks for most people.
Dosing may only be once per month
The thought of an injection may be scary, but after the initial few doses, most biologics are administered only once every two months. This may be once every month if your condition does not respond. However, it may be reassuring to know that the needle is very small, and the medication is injected just under your skin.
Most biologics are also offered in the form of an auto-injector, which means you can get the injections without ever seeing a needle. You can even give yourself certain biologics at home after you're trained properly on how to do so. Some self-administered biologics may need to be given biweekly, such as Humira and Entyvio.
They may have fewer side effects than steroids
Corticosteroids, such as prednisone or budesonide, work by suppressing the entire immune system.
Biologics, on the other hand, work in a more selective way by targeting specific proteins in your immune system that are proven to be associated with Crohn's inflammation. As they are more precise, they typically have fewer side effects than corticosteroids.
However, almost all drugs carry the risk of side effects. For biologics, the most common side effects are related to how they're administered. You might experience minor irritation, redness, pain, or a reaction at the site of injection.
There's also a slightly higher risk of infection, but the risk is not as high as with other drugs, such as corticosteroids.
»MORE: What to know about switching to biologics
Biologics safety
The first biologic for Crohn's disease was approved in 1998, so biologics have quite a bit of experience and safety testing to show for themselves.
You may be hesitant to try a biologic because you heard they were 'strong' drugs, or you're concerned about the high costs. However, while biologics are considered a more aggressive treatment option, they're also more targeted drugs, and they work very well.
Unlike some older treatments for Crohn's disease that weaken the whole immune system, biologic drugs target specific inflammatory proteins known to be involved in Crohn's disease. In contrast, corticosteroid drugs suppress your entire immune system.
However, you'll still want to consider all side effects and discuss with your doctor whether biologics are the best option for you.
Choosing a biologic
Before biologics, there were few treatment options aside from surgery for people with severe Crohn's disease. Now, there are several options:
adalimumab (Humira, Exemptia)
certolizumab pegol (Cimzia)
infliximab (Remicade, Remsima, Inflectra)
natalizumab (Tysabri)
ustekinumab (Stelara)
vedolizumab (Entyvio)
risankizumab (Skyrizi)
guselkumab (Tremfya)
You'll have to work with your insurance company to find out whether a particular biologic is covered under your plan.
Takeaway
Biologic medications are targeted treatment options for Crohn's disease and other autoimmune conditions. They are typically strong but effective and may have fewer side effects than some other traditional treatments.
However, like with all drugs, there are things you'll want to consider to determine if this option is right for you. Certain factors may mean this type of treatment is suitable for you, but it'll depend on your specific circumstances. Speaking with your doctor can help you figure out if biologics are a good option.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector
UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector

Yahoo

time36 minutes ago

  • Yahoo

UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector

UnitedHealth Group Incorporated UNH continues to face challenges amid a turbulent healthcare insurance landscape. The passage of the 'One Big Beautiful Bill Act' through Congress, ready for President Donald Trump's signature, threatens to significantly reduce federal Medicaid spending. According to reports, approximately 11.8 million Americans are expected to lose Medicaid coverage by 2034, with 5.2 million affected by new work requirements alone. To curb state-level Medicaid expenditures, the bill gradually limits the use of 'provider taxes' as a revenue source. However, it also allocates $50 billion in funding to support rural hospitals impacted by these cuts. While insurers like UnitedHealth and Humana Inc. HUM may encounter short-term pressure from shrinking Medicaid rolls, they could ultimately benefit as displaced members shift toward private coverage options. UnitedHealth's Medicaid membership declined 4% in 2023, 5.2% in 2024, and 1.4% in the first quarter of 2025. The proposed elimination of ACA marketplace tax credits will likely propel more people into employer-sponsored plans. Meanwhile, Medicare Advantage may gain traction, as seniors grapple with increased out-of-pocket expenses due to rollbacks in Medicare Savings Programs. UnitedHealth's Medicare Advantage enrollment rose by 8.3% in 2023, 1.9% in 2024, and 6.3% in the first quarter of 2025. Another major development shook the market as Centene Corporation CNC, a major Medicaid player, withdrew its 2025 earnings guidance late Tuesday, citing unexpected enrollment shifts and higher medical costs. The move, mirroring UnitedHealth's earlier decision, rattled the managed care sector. Centene shares witnessed massive declines following the news, and peers like UnitedHealth and Humana followed suit. Centene shares plummeted 41.2% following the announcement, dragging down peers: UnitedHealth and Humana dropped 5.4% and 5.1%, respectively, despite broader market gains driven by tech strength and encouraging jobs data. Image Source: Zacks Investment Research From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 12.99, up from the industry average of 11.49. UNH currently carries a Value Score of A. Image Source: Zacks Investment Research The Zacks Consensus Estimate for UnitedHealth's 2025 earnings is pegged at $22.07 per share, implying a 20.2% drop from the year-ago period. Image Source: Zacks Investment Research The stock currently carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Humana Inc. (HUM) : Free Stock Analysis Report Centene Corporation (CNC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years
Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

Yahoo

timean hour ago

  • Yahoo

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

It is doubtless a positive to see that the OptimizeRx Corporation (NASDAQ:OPRX) share price has gained some 73% in the last three months. But that is small recompense for the exasperating returns over three years. Indeed, the share price is down a tragic 55% in the last three years. Some might say the recent bounce is to be expected after such a bad drop. While many would remain nervous, there could be further gains if the business can put its best foot forward. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Because OptimizeRx made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. Over three years, OptimizeRx grew revenue at 16% per year. That's a fairly respectable growth rate. So some shareholders would be frustrated with the compound loss of 16% per year. The market must have had really high expectations to be disappointed with this progress. So this is one stock that might be worth investigating further, or even adding to your watchlist. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So we recommend checking out this free report showing consensus forecasts It's good to see that OptimizeRx has rewarded shareholders with a total shareholder return of 34% in the last twelve months. Notably the five-year annualised TSR loss of 1.3% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - OptimizeRx has 1 warning sign we think you should be aware of. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The heat has a surprising effect on the brain — here's what doctors want you to know
The heat has a surprising effect on the brain — here's what doctors want you to know

Fox News

timean hour ago

  • Fox News

The heat has a surprising effect on the brain — here's what doctors want you to know

Summer heat has swept the U.S., with warnings issued across the East Coast and Midwest. In addition to putting stress on the body, hot weather can also take a toll on the brain and mental health. Dr. Jace Reed, director of emergency psychiatry at Cedars-Sinai Hospital in Los Angeles, emphasized in an interview with Fox News Digital that the brain is a major organ that can be greatly affected by heat. Extreme heat can cause mental health changes like increased irritability and anxiety, along with decreased memory, attention and reaction time. This can affect daily interactions socially and professionally, the expert cautioned. "You may be slower at completing your task or remembering what someone just told you," he told Fox News Digital. "Those can be initial early signs that the heat is affecting your brain and your mental abilities." Symptoms like extreme confusion could mark the beginning of a heat stroke, which could require hospitalization, the psychiatrist warned. In a separate interview with Fox News Digital, Thea Gallagher, a doctor of psychology and director of wellness programs at NYU Langone Health, noted that when the body overheats, it struggles to regulate internal balance. This can lead to disrupted sleep, fatigue and poor concentration, as well as impaired cognitive function, slow reaction times and struggles with decision-making. The heat can also increase oxidative stress and inflammation in the brain, Gallagher added, which can potentially damage neurons, worsen existing neurological conditions and raise stroke risk. "Heat exposure may trigger an inflammatory response in the brain," she said. "In cases like heatstroke, inflammation is believed to contribute to symptoms such as confusion and delirium." Excessive heat can also weaken the protective blood-brain barrier, according to the expert, which makes the brain more vulnerable to toxins and pathogens. Higher temperatures are also associated with disturbances in mood and violent behavior, especially during prolonged heatwaves. Psychiatric emergency visits for anxiety, depression and substance use also rise significantly on the hottest days, Gallagher confirmed. Below are some of the main mental symptoms that can worsen in hot weather, experts cautioned. People who suffer from mental health conditions such as mood disorders, schizophrenia, anxiety or even dementia are more vulnerable in hot weather. Some psychiatric medications could make it difficult for the body to regulate temperature or stay hydrated, Gallagher noted, while heat can "intensify" symptoms like agitation or paranoia. "People with cognitive impairments may not recognize the signs of overheating," she added. "Some SSRIs (selective serotonin reuptake inhibitors) can suppress sweat production, which is the body's primary cooling mechanism. This raises the risk of overheating, dehydration and even heat stroke." "Paradoxically, SSRIs can also cause excessive sweating in some individuals — a side effect known as 'SSRI sweats,'" she went on. "While this might seem like it would help with cooling, it can actually lead to dehydration if fluid intake doesn't keep up." The experts recommended the following practices to protect brain health in extreme heat. For more Health articles, visit "Days are also longer and there are more activities, which can be exhausting," Gallagher noted. "Therefore, it is good to prioritize sleep and rest … and [find] ways to slow down when you can."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store